Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regulation of Cervical Mucus Secretion
NCT02969590Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Mar 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of norethindrone in contraception (3 arms), sponsored by Oregon Health & Science University. Primary endpoints: Median Cervical Mucus Score at 24 hours and Sperm Penetration Scores at 1 year. Started Mar 2015; status: completed.
02
Drugs
norethindrone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02969590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02969590.